Abnova FISH probes for cancer research
Abnova provides a collection of fluorescence in situ hybridisation (FISH) probes targeting various potential prognostic biomarkers for oncology. The company’s cytogenetic probes enable high hybridisation efficiency, ready for the rapid identification of chromosomal abnormalities — such as amplifications, translocation, fusion and splitting — that are frequently encountered across the genome.
Designed for the purpose of pinpointing DNA targets in cells and in tissues, the FISH probes will facilitate further research for lung adenocarcinoma, ovarian cancer, pancreatic cancer, prostate cancer and more.
Phone: 02 9698 2022
Amsbio Acepix FFPE tissue blocks
Amsbio has expanded its range of high-quality formalin-fixed, paraffin-embedded (FFPE) tissues...
Promega Paradyme 27GY STR System
The Paradyme 27GY STR System features a novel enzyme that reduces the most common type of...
Mercodia Insulin MBeads Assay
The assay is designed to offer high accuracy by specifically measuring human insulin while...
